Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | AGXT | P21549 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TACR1 | P25103 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28229246 | 0.77 | ALDH1A1 (0.38) | TSHRALDH1A1CA1CA2POLB | |
| SCHEMBL532592 | 0.77 | CYP11B1 (0.61) | POLBLTA4H | |
| SCHEMBL27380 | 0.75 | TSHR (1.00) | TSHRIDO1AGXTALDH1A1CA1 | |
| Benzene SCHEMBL27997624 | 0.75 | TSHR (1.00) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL5311581 | 0.75 | TSHR (1.00) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL1563130 | 0.75 | TSHR (0.48) | TSHRIDO1AGXTALDH1A1KDM4E | |
| SCHEMBL9725547 | 0.73 | TSHR (0.94) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL9795394 | 0.73 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| Barium SCHEMBL3798966 | 0.73 | TSHR (0.94) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL9491202 | 0.73 | TSHR (0.94) | TSHRIDO1AGXTALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101495117-B | Aqueous liquid preparation containing amide compound | SENJU PHARMA CO | 2012-08-15 | — | — | CN | disclosed |
| CN-100548375-C | Antitumor effect potentiators | MITSUBISHI PHARMACEUTICALS CO (JP) | 2009-10-14 | — | — | CN | disclosed |
| CN-101495117-A | Aqueous liquid preparation containing amide compound | SENJU PHARMA CO (JP) | 2009-07-29 | — | — | CN | disclosed |
| CN-100438910-C | Preventives/remedies for liver diseases | MITSUBISHI PHARMACEUTICAL CO L (JP) | 2008-12-03 | — | — | CN | disclosed |
| CN-1293878-C | Preventing or curing agent for eye fatigue and pseudomyopia | SENJU PHARMA CO (JP) | 2007-01-10 | — | — | CN | disclosed |
| WO-2006073938-A2 | METHOD FOR THE SYNTHESIS OF 3-SUBSTITUTED INDOLIZINE AND BENZOINDOLIZINE COMPOUNDS | EAST CAROLINA UNIVERSITY (US) | 2006-07-13 | — | — | WO | disclosed |
| CN-1195547-C | Preventive/remedy for glaucoma | SENJI PHARMACEUTICAL CO LTD (JP) | 2005-04-06 | — | — | CN | disclosed |
| CN-1494903-A | Preventing or curing agent for eye fatigue and pseudomyopia | ǧ����ҩ��ʽ���� | 2004-05-12 | — | — | CN | disclosed |